Low rates of haemorrhagic stroke, not increased by age, renal/hepatic impairment, concomitant anti-platelet use and high CHA2DS2-VASc scores, in the 4-year follow-up of ETNA-AF-Europe - KIVIRID

Low rates of haemorrhagic stroke, not increased by age, renal/hepatic impairment, concomitant anti-platelet use and high CHA2DS2-VASc scores, in the 4-year follow-up of ETNA-AF-Europe

Authors: D Morrone, R Chhabra, E M Fronk, P Kirchhof, R De Caterina

Published: 2024-10-28

DOI: 10.1093/eurheartj/ehae666.2311

Source: Full article

Abstract

Abstract